1. Home
  2. IMNM vs UVE Comparison

IMNM vs UVE Comparison

Compare IMNM & UVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • UVE
  • Stock Information
  • Founded
  • IMNM 2006
  • UVE 1990
  • Country
  • IMNM United States
  • UVE United States
  • Employees
  • IMNM N/A
  • UVE N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • UVE Property-Casualty Insurers
  • Sector
  • IMNM Health Care
  • UVE Finance
  • Exchange
  • IMNM Nasdaq
  • UVE Nasdaq
  • Market Cap
  • IMNM 748.3M
  • UVE 642.7M
  • IPO Year
  • IMNM 2020
  • UVE 1992
  • Fundamental
  • Price
  • IMNM $9.06
  • UVE $28.29
  • Analyst Decision
  • IMNM Strong Buy
  • UVE
  • Analyst Count
  • IMNM 5
  • UVE 0
  • Target Price
  • IMNM $26.40
  • UVE N/A
  • AVG Volume (30 Days)
  • IMNM 973.9K
  • UVE 262.9K
  • Earning Date
  • IMNM 05-12-2025
  • UVE 07-24-2025
  • Dividend Yield
  • IMNM N/A
  • UVE 2.27%
  • EPS Growth
  • IMNM N/A
  • UVE N/A
  • EPS
  • IMNM N/A
  • UVE 2.29
  • Revenue
  • IMNM $10,938,000.00
  • UVE $1,547,444,000.00
  • Revenue This Year
  • IMNM N/A
  • UVE N/A
  • Revenue Next Year
  • IMNM $542.22
  • UVE $1.13
  • P/E Ratio
  • IMNM N/A
  • UVE $12.31
  • Revenue Growth
  • IMNM N/A
  • UVE 7.24
  • 52 Week Low
  • IMNM $5.15
  • UVE $16.50
  • 52 Week High
  • IMNM $16.81
  • UVE $28.26
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 61.94
  • UVE 76.40
  • Support Level
  • IMNM $8.50
  • UVE $26.02
  • Resistance Level
  • IMNM $9.04
  • UVE $26.88
  • Average True Range (ATR)
  • IMNM 0.54
  • UVE 0.59
  • MACD
  • IMNM 0.09
  • UVE 0.04
  • Stochastic Oscillator
  • IMNM 90.18
  • UVE 100.00

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums. It operates within Florida and across the United States. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

Share on Social Networks: